Size transformations of intermediate and low density lipoproteins induced by unesterified fatty acids
- PMID: 1940623
Size transformations of intermediate and low density lipoproteins induced by unesterified fatty acids
Abstract
Plasma from individual human subjects is known to contain multiple discrete subpopulations of low (LDL) and intermediate (IDL) density lipoproteins that differ in particle size and density. The metabolic origins of these subpopulations are unknown. Transformation of IDL and larger LDL to smaller, denser LDL particles had been postulated to occur as a result of the combined effects of triglyceride hydrolysis and lipid transfer. However, the presence of multiple small LDL subspecies has been described in patients lacking cholesteryl ester transfer protein. We have characterized an alternative pathway in which size decrements in IDL or LDL are produced in the presence of unesterified fatty acids and a source of apolipoprotein (apo) A-I. Incubation of IDL or LDL subfractions with palmitic acid and either high density lipoproteins (HDL), apoHDL, or purified apoA-I gives rise to apoA-I, apoB-containing complexes that can dissociate into two particles, an apoB-containing lipoprotein with particle diameter 10-30 A smaller than the starting material, and a still smaller species (apparent peak particle diameter 140-190 A) containing lipid and apoA-I but no apoB. The newly formed IDL or LDL are depleted in phospholipid and free cholesterol with no change in apoB-100 as assessed by SDS gel electrophoresis. We hypothesize that this reaction may contribute to the formation of discrete IDL and LDL subpopulations of varying size during the course of hydrolysis of triglyceride-rich lipoproteins in plasma.
Similar articles
-
Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.J Lipid Res. 1991 Jun;32(6):917-33. J Lipid Res. 1991. PMID: 1940624
-
Plasma lipoproteins in the golden Syrian hamster (Mesocricetus auratus): heterogeneity of apoB- and apoA-I-containing particles.J Lipid Res. 1993 Jun;34(6):943-59. J Lipid Res. 1993. PMID: 8354960
-
Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.Atherosclerosis. 2002 Aug;163(2):287-96. doi: 10.1016/s0021-9150(02)00037-0. Atherosclerosis. 2002. PMID: 12052475 Clinical Trial.
-
Characterization of lipoproteins produced by the human liver cell line, Hep G2, under defined conditions.J Lipid Res. 1986 Mar;27(3):236-50. J Lipid Res. 1986. PMID: 3016129 Review.
-
Metabolic origins and clinical significance of LDL heterogeneity.J Lipid Res. 2002 Sep;43(9):1363-79. doi: 10.1194/jlr.r200004-jlr200. J Lipid Res. 2002. PMID: 12235168 Review.
Cited by
-
Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans.Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10886-90. doi: 10.1073/pnas.90.22.10886. Proc Natl Acad Sci U S A. 1993. PMID: 8248186 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous